LONDON BROKER RATINGS: JPMorgan, Barclays cut price targets for Greggs
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More
| Price | 207.20p on 11-03-2026 at 19:30:05 |
|---|---|
| Change | 1.30p 0.63% |
| Buy | 207.60p |
| Sell | 207.40p |
| Last Trade: | Sell 6,849.00 at 207.20p |
| Day's Volume: | 13,175,588 |
| Last Close: | 207.20p |
| Open: | 207.40p |
| ISIN: | GB0030913577 |
| Day's Range | 205.70p - 208.60p |
| 52wk Range: | 148.90p - 223.60p |
| Market Capitalisation: | £20.18b |
| VWAP: | 207.28158p |
| Shares in Issue: | 9.74b |
BT (BT.A) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 6,849 | 207.20p | SI Trade |
16:35:11 - 11-Mar-26 |
| Sell* | 25 | 207.20p | SI Trade |
16:35:11 - 11-Mar-26 |
| Sell* | 7 | 207.20p | SI Trade |
16:35:11 - 11-Mar-26 |
| Sell* | 18 | 207.20p | SI Trade |
16:35:11 - 11-Mar-26 |
| Sell* | 10 | 207.20p | SI Trade |
16:35:11 - 11-Mar-26 |
| Sell* | 33,800 | 207.20p | SI Trade |
16:35:11 - 11-Mar-26 |
| Sell* | 42,694 | 207.20p | SI Trade |
16:35:11 - 11-Mar-26 |
| Sell* | 5,411 | 207.20p | Automatic Execution |
16:35:11 - 11-Mar-26 |
| Sell* | 5,398 | 207.20p | Automatic Execution |
16:35:11 - 11-Mar-26 |
| Sell* | 4,302 | 207.20p | Automatic Execution |
16:35:11 - 11-Mar-26 |
BT (BT.A) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 27th Feb 2026 11:00 am | RNS | Total Voting Rights |
| 13th Feb 2026 10:30 am | RNS | Director/PDMR Shareholding |
| 11th Feb 2026 2:00 pm | RNS | Director/PDMR Shareholding |
| 10th Feb 2026 7:00 am | RNS | New leaders for Openreach and BT International |
| 5th Feb 2026 7:00 am | RNS | Trading update for nine months to 31 December 2025 |
| 30th Jan 2026 1:52 pm | RNS | Total Voting Rights |
| 31st Dec 2025 11:25 am | RNS | Total Voting Rights |
| 31st Dec 2025 11:25 am | RNS | Total Voting Rights |
| 23rd Dec 2025 12:30 pm | RNS | Director/PDMR Shareholding |
| 23rd Dec 2025 12:30 pm | RNS | Director/PDMR Shareholding |